Influenza

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies—Momenta Pharmaceuticals, Cerulean Pharma, and Visterra—share a similar goal. "It's about the impact we can have on patient care," says Sasisekharan, ...

Apr 28, 2014
popularity 4 / 5 (2) | comments 0

Study recalculates costs of combination vaccines

One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive ...

Apr 17, 2014
popularity 2 / 5 (1) | comments 0

Tracking flu levels with Wikipedia

Can monitoring Wikipedia hits show how many people have the flu? Researchers at Boston Children's Hospital, USA, have developed a method of estimating levels of influenza-like illness in the American population by analysing ...

Apr 17, 2014
popularity not rated yet | comments 0

Tamiflu and Relenza: How effective are they?

Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza. This is according ...

Apr 11, 2014
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

Scientists discover gene controlling muscle fate

Scientists at the University of New Mexico have moved a step closer to improving medical science through research involving muscle manipulation of fruit flies. They discovered in the flight muscles of Drosophila ...